Medicine and Dentistry
Patient
100%
Therapeutic Procedure
66%
Chemotherapy
60%
Non Small Cell Lung Cancer
34%
Platinum
32%
Biological Marker
29%
Diagnosis
26%
Survival
25%
Protein
24%
Mesothelioma
22%
Radiation Pneumonia
22%
Radiation Therapy
19%
Pemetrexed
18%
Marker
16%
Pleura Mesothelioma
15%
Inpatient
15%
Overall Survival
14%
Diseases
13%
Neoplasm
12%
Erlotinib
11%
Triacylglycerol
11%
Membrane Microparticle
11%
Exosome
11%
Drug Megadose
11%
Adverse Event
10%
Immunohistochemistry
9%
Effusion
9%
Mortality
9%
Malignant Neoplasm
8%
Metabolite
8%
Cholesterol
8%
Plasma
8%
Supportive Care
7%
Combination Therapy
7%
Minimal Residual Disease
7%
Age
6%
Surgery
6%
Specimen
6%
Sarcomatoid
6%
Biopsy
6%
Learning
6%
Patient with Cancer
6%
Lung Cancer
6%
Cisplatin
5%
Epidermal Growth Factor Receptor
5%
Serum
5%
Enalapril Maleate
5%
Analysis
5%
Introspection
5%
Nursing and Health Professions
Patient
36%
Inpatient
29%
Dose
18%
Non Small Cell Lung Cancer
13%
Fractional Exhaled Nitric Oxide
12%
Erlotinib
11%
Drug Megadose
11%
Mortality
9%
Random Forest
9%
Death
9%
Chemotherapy
8%
Platinum
8%
Decision Support System
6%
Lung Cancer
6%
Epidermal Growth Factor Receptor
5%
Cisplatin
5%
Biochemistry, Genetics and Molecular Biology
BAP1
22%
Phosphorylase
22%
Radiation
22%
Sample
21%
Microvesicles
11%
Electric Potential
10%
Random Forest
9%
Tree
9%
Mortality
9%
Cholesterol
8%
Tissue Section
6%
Learning
6%
Decision Support System
6%
Time
5%
Dynamics
5%
Introspection
5%
